Zobrazeno 1 - 10 of 24 pro vyhledávání: '"N I, Olovnikova"'
1
Production of IgM monoclonal antibodies in DG44 cells
Autor: N. I. Olovnikova, M. A. Ershler
Publikováno v: Applied Biochemistry and Microbiology. 50:819-828
Two-bicistronic vectors for the production of recombinant IgM monoclonal antibodies in the DG44 DHFR-negative cell line have been designed. We used tandem vectors, in which one bicistronic unit encoded the immunoglobulin light chain and DHFR and the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3d1f7e534c9f83ce7c0db0f993cff3e2
https://doi.org/10.1134/s0003683814090026
Zobrazit plný text záznamu
2
Is an expression system for producing therapeutic antibodies with immunosuppressive properties found at last? Comment to letter by Dr. Quagliaroli
Autor: N. I. Olovnikova
Publikováno v: Biochemistry. Biokhimiia. 78(12)
The prophylaxis of the hemolytic disease of the newborn — a mandatory procedure in obstetrics — requires significant amounts of plasma-derived polyclonal anti-D immunoglobulin. Despite numerous attempts, the proper technology for mass production
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd38ed56e9ee710c1f474fcf8c673355
https://pubmed.ncbi.nlm.nih.gov/24460972
Zobrazit plný text záznamu
3
Effector properties and glycosylation patterns of recombinant human anti-D-IgG1 antibodies produced by human PER.C6(®) cells
Autor: N. I. Olovnikova, O. V. Grigorieva, A. V. Petrov
Publikováno v: Bulletin of experimental biology and medicine. 154(2)
Creation of effective monoclonal anti-D immunoglobulin for prevention of hemolytic disease of the newborn remains an unsolved problem because there is still no producer cell strain providing stable production and adequate glycosylation of antibodies.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::747c7f9f119ccf0cb2fdc06c14cdf3fc
https://pubmed.ncbi.nlm.nih.gov/23330136
Zobrazit plný text záznamu
8
[Immunoglobulin G monoclonal human anti-rhesus Rho(D) to prevent rhesus-incompatibility]
Autor: N I, Olovnikova, E V, Belkina, N I, Drize, A G, Konopliannikov, L N, Lemeneva, G Iu, Miterev, T L, Nikolaeva, G M, Savel'eva, I L, Chertkov
Publikováno v: Klinicheskaia meditsina. 75(7)
RhD immunisation which follows pregnancy can be prevented by administration to the rhesus-negative mother of 20 micrograms anti-D immunoglobulin per 1 ml of D-positive fetal red cells in the maternal circulation. With the aim of substitution of polyc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fa61036c7b282a3dfcde3227c4041d69
https://pubmed.ncbi.nlm.nih.gov/9411052
Zobrazit plný text záznamu
10
[Monoclonal anti-D immunoglobulin for prevention of hemolytic disease of the newborn]
Autor: N I, Olovnikova, E V, Belkina, A L, Berkovskiĭ, L N, Lemeneva, T L, Nikolaeva, I L, Chertkov
Publikováno v: Gematologiia i transfuziologiia. 39(4)
Stable human-mouse heterohybridoma producing human monoclonal anti-D IgG1 has been derived by fusing Epstein-Barr virus (EBV) transformed human immune lymphocytes with mouse myeloma. The absence of EBV DNA in heterohybridoma was demonstrated by the p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::db2a2152fca474b3c569830a96710c04
https://pubmed.ncbi.nlm.nih.gov/7875519
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje